Insider · CIK 0001197023
Joshua S Boger
Files at CRVO (CervoMed Inc.). First filing Jun 15, 2026, latest Jun 15, 2026.
In brief
Joshua S Boger files SEC Form 4 as director and 10% owner at CRVO (CervoMed Inc.). Since Jun 15, 2026, Joshua S Boger has reported 1 open-market buy worth $3.0M and 0 open-market sells worth $0, the latest filed on Jun 15, 2026.
A track record needs three past buys with six months of prices behind them; Joshua S Boger has 0, so none is measured yet.
The newest scored trade: bought $3.0M of CRVO on Jun 11, 2026, filed Jun 15, 2026, scored 68 (notable). In the last 12 months: 1 buy worth $3.0M and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CRVO: CervoMed Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 68Notable | CRVObuy CervoMed Inc. | $3.0M 955,414 shares | +114% | +8% from low-77% from high |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | CRVO CervoMed Inc. | POpen-market purchase Common Stockindirect: By Trusts | +955,414 | $3.14 | $3.0M | 1,795,865 | Jun 15, 2026 |
| Jun 11, 2026 | CRVO CervoMed Inc. | POpen-market purchase Series B Warrantsderivativeindirect: By Trust | +955,414 | - | - | 955,414 | Jun 15, 2026 |
| Jun 11, 2026 | CRVO CervoMed Inc. | POpen-market purchase Series C Warrantsderivativeindirect: By Trust | +955,414 | - | - | 955,414 | Jun 15, 2026 |
| Jun 8, 2026 | CRVO CervoMed Inc. | AGrant or award Stock Option (Right to Buy)derivative | +8,150 | $0.00 | $0 | 8,150 | Jun 10, 2026 |
| Jun 23, 2025 | CRVO CervoMed Inc. | AGrant or award Stock Option (Right to Buy)derivative | +8,100 | $0.00 | $0 | 8,100 | Jun 25, 2025 |
| Feb 26, 2024 | CRVO CervoMed Inc. | XIn-the-money exercise Common Stockindirect: By Trusts | +495,995 | - | - | 840,487 | Feb 28, 2024 |
| Feb 26, 2024 | CRVO CervoMed Inc. | SOpen-market sale Common Stockindirect: By Trusts | -36 | - | - | 840,451 | Feb 28, 2024 |
| Feb 26, 2024 | CRVO CervoMed Inc. | XIn-the-money exercise Pre-Funded Common Stock Purchase Warrantderivativeindirect: By Trusts | -495,995 | - | - | 0 | Feb 28, 2024 |
| Feb 12, 2024 | CRVO CervoMed Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Feb 13, 2024 |
Questions about Joshua S Boger
Answered from the filings on this page, as of the latest one.
Is Joshua S Boger buying or selling?
In the last 12 months Joshua S Boger reported 1 open-market buy worth $3.0M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $3.0M of CRVO on Jun 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Joshua S Boger's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joshua S Boger has 0.
Where does Joshua S Boger file Form 4?
Joshua S Boger has filed Form 4 at CRVO (CervoMed Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.